AAIS
REGN icon

ABN AMRO Investment Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

ABN AMRO Investment Solutions’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.81M Buy
6,114
+1,254
+26% +$854K 0.03% 297
2026
Q1 		$3.76M Buy
4,860
+503
+12% +$385K 0.05% 246
2025
Q4 		$3.36M Sell
4,357
-2,427
-36% -$1.65M 0.05% 240
2025
Q3 		$3.81M Sell
6,784
-854
-11% -$483K 0.08% 181
2025
Q2 		$4.01M Sell
7,638
-27,102
-78% -$15.1M 0.08% 186
2025
Q1 		$22M Sell
34,740
-2,635
-7% -$1.81M 0.46% 51
2024
Q4 		$26.6M Sell
37,375
-1,725
-4% -$1.45M 0.5% 57
2024
Q3 		$41.1M Buy
39,100
+1,146
+3% +$1.28M 0.72% 38
2024
Q2 		$39.9M Sell
37,954
-2,476
-6% -$2.4M 0.72% 38
2024
Q1 		$38.9M Buy
40,430
+16,081
+66% +$15.3M 0.67% 41
2023
Q4 		$21.4M Buy
24,349
+1,871
+8% +$1.54M 0.38% 60
2023
Q3 		$18.5M Buy
22,478
+460
+2% +$362K 0.36% 66
2023
Q2 		$15.8M Buy
22,018
+4,777
+28% +$3.68M 0.32% 83
2023
Q1 		$14.2M Buy
+17,241
New +$13M 0.29% 90

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

ABN AMRO Investment Solutions's REGN Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Regeneron Pharmaceuticals (REGN) stake by 26% in Q2 2026, buying an estimated $854K and bringing the position to 6,114 shares worth $3.81M. The position accounts for 0.03% of the portfolio, ranked #297.

ABN AMRO Investment Solutions first reported a position in REGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $41.1M in Q3 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • ABN AMRO Investment Solutions held 6,114 shares of Regeneron Pharmaceuticals worth $3.81M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 1,254 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $854K.
  • Regeneron Pharmaceuticals made up 0.03% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #297 holding.
  • ABN AMRO Investment Solutions first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Investment Solutions's Regeneron Pharmaceuticals position peaked at $41.1M in Q3 2024.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.